UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 7, 2012
IASIS HEALTHCARE LLC
(Exact name of registrant as specified in its charter)
Delaware | 333-117362 | 20-1150104 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) |
(IRS Employer Identification No.) | ||
117 Seaboard Lane, Building E Franklin, Tennessee |
37067 | |||
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (615) 844-2747
Not Applicable
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 | Regulation FD Disclosure. |
On June 7, 2012, IASIS Healthcare LLC (the Company) announced that $115.2 million in cash remains on the balance sheet of its sole owner and parent company, IASIS Healthcare Corporation (the Corporation), to be used to fund potential Company acquisitions and development projects, and for general corporate purposes. The Corporation had received $230.0 million in a refinancing of the Companys indebtedness in May 2011 and has used $115.0 million of such cash to redeem all of the Corporations issued and outstanding Series A Cumulative Convertible Preferred Stock and to pay a dividend to the Corporations common stockholders. The combination of capital at both the Corporation and the Company, along with access to other sources of funding, continues to provide the Company a platform for future growth through acquisitions and other development projects.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IASIS HEALTHCARE LLC | ||
By: | /s/ John M. Doyle | |
John M. Doyle | ||
Chief Financial Officer |
Date: June 7, 2012